Industry Research Reports

Home > Reports > Pharma & Healthcare > Subcutaneous Immunoglobulins- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Subcutaneous Immunoglobulins- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Industry: Pharma & Healthcare

Published Date: 2025-01-16

Pages: 90 Pages

Report ld: 3479883

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Subcutaneous Immunoglobulins Market Size(US$)

CAGR 2025-2031

12.1%

Market Size,2031

USD 12,050

Million

Market Snapshot

Market Size in 2025 (Value)

US$ 6,087 million

Market Forecast in 2031(Value)

US$ 12,050 million

CAGR

12.1%

Years Considered

2020-2031

Base Year

2025

Forecast Period

2025-2031

Source: Secondary research, interviews with experts, and QYResearch analysis

The global market for Subcutaneous Immunoglobulins was estimated to be worth US$ 5491 million in 2024 and is forecast to a readjusted size of US$ 12050 million by 2031 with a CAGR of 12.1% during the forecast period 2025-2031.

Subcutaneous Immunoglobulin (SCIg) infusions are administered by slowly injecting purified immunoglobulin into fatty tissue underneath the skin. SCIg can be administered at home by patients or carers, using an infusion pump (spring loaded or battery powered) or by rapid push (a manual method that does not require a pump).

In United States, Subcutaneous Immunoglobulins key players include Shire (Baxalta), Grifols, etc. Global top two manufacturers hold a share over 90%.

South is the largest market, with a share about 35%, followed by West, and Northeast, both have a share about 45 percent.

In terms of product, 10% Purity is the largest segment, with a share over 75%. And in terms of application, the largest application is Primary Immunodeficiency, followed by Secondary Immunodeficiency, etc.

This report aims to provide a comprehensive presentation of the global market for Subcutaneous Immunoglobulins, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Subcutaneous Immunoglobulins by region & country, by Purity, and by Application.

The Subcutaneous Immunoglobulins market size, estimations, and forecasts are provided in terms of sales volume (K Bottle) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Subcutaneous Immunoglobulins.

MARKET SEGMENTATION

By Company

Shire (Baxalta)
Grifols
CSL

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Segment by Application

Primary Immunodeficiency
Secondary Immunodeficiency
Others

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Subcutaneous Immunoglobulins manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Purity, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Subcutaneous Immunoglobulins in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Subcutaneous Immunoglobulins in country level. It provides sigmate data by Purity, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Subcutaneous Immunoglobulins Product Introduction

1.2 Global Subcutaneous Immunoglobulins Market Size Forecast

1.2.1 Global Subcutaneous Immunoglobulins Sales Value (2020-2031)

1.2.2 Global Subcutaneous Immunoglobulins Sales Volume (2020-2031)

1.2.3 Global Subcutaneous Immunoglobulins Sales Price (2020-2031)

1.3 Subcutaneous Immunoglobulins Market Trends & Drivers

1.3.1 Subcutaneous Immunoglobulins Industry Trends

1.3.2 Subcutaneous Immunoglobulins Market Drivers & Opportunity

1.3.3 Subcutaneous Immunoglobulins Market Challenges

1.3.4 Subcutaneous Immunoglobulins Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Subcutaneous Immunoglobulins Players Revenue Ranking (2024)

2.2 Global Subcutaneous Immunoglobulins Revenue by Company (2020-2025)

2.3 Global Subcutaneous Immunoglobulins Players Sales Volume Ranking (2024)

2.4 Global Subcutaneous Immunoglobulins Sales Volume by Company Players (2020-2025)

2.5 Global Subcutaneous Immunoglobulins Average Price by Company (2020-2025)

2.6 Key Manufacturers Subcutaneous Immunoglobulins Manufacturing Base and Headquarters

2.7 Key Manufacturers Subcutaneous Immunoglobulins Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Subcutaneous Immunoglobulins

2.9 Subcutaneous Immunoglobulins Market Competitive Analysis

2.9.1 Subcutaneous Immunoglobulins Market Concentration Rate (2020-2025)

2.9.2 Global 5 and 10 Largest Manufacturers by Subcutaneous Immunoglobulins Revenue in 2024

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Subcutaneous Immunoglobulins as of 2024)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Purity

3.1 Introduction by Purity

3.1.1 0.1

3.1.2 0.2

3.2 Global Subcutaneous Immunoglobulins Sales Value by Purity

3.2.1 Global Subcutaneous Immunoglobulins Sales Value by Purity (2020 VS 2024 VS 2031)

3.2.2 Global Subcutaneous Immunoglobulins Sales Value, by Purity (2020-2031)

3.2.3 Global Subcutaneous Immunoglobulins Sales Value, by Purity (%) (2020-2031)

3.3 Global Subcutaneous Immunoglobulins Sales Volume by Purity

3.3.1 Global Subcutaneous Immunoglobulins Sales Volume by Purity (2020 VS 2024 VS 2031)

3.3.2 Global Subcutaneous Immunoglobulins Sales Volume, by Purity (2020-2031)

3.3.3 Global Subcutaneous Immunoglobulins Sales Volume, by Purity (%) (2020-2031)

3.4 Global Subcutaneous Immunoglobulins Average Price by Purity (2020-2031)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Primary Immunodeficiency

4.1.2 Secondary Immunodeficiency

4.1.3 Others

4.2 Global Subcutaneous Immunoglobulins Sales Value by Application

4.2.1 Global Subcutaneous Immunoglobulins Sales Value by Application (2020 VS 2024 VS 2031)

4.2.2 Global Subcutaneous Immunoglobulins Sales Value, by Application (2020-2031)

4.2.3 Global Subcutaneous Immunoglobulins Sales Value, by Application (%) (2020-2031)

4.3 Global Subcutaneous Immunoglobulins Sales Volume by Application

4.3.1 Global Subcutaneous Immunoglobulins Sales Volume by Application (2020 VS 2024 VS 2031)

4.3.2 Global Subcutaneous Immunoglobulins Sales Volume, by Application (2020-2031)

4.3.3 Global Subcutaneous Immunoglobulins Sales Volume, by Application (%) (2020-2031)

4.4 Global Subcutaneous Immunoglobulins Average Price by Application (2020-2031)

5 Segmentation by Region

5.1 Global Subcutaneous Immunoglobulins Sales Value by Region

5.1.1 Global Subcutaneous Immunoglobulins Sales Value by Region: 2020 VS 2024 VS 2031

5.1.2 Global Subcutaneous Immunoglobulins Sales Value by Region (2020-2025)

5.1.3 Global Subcutaneous Immunoglobulins Sales Value by Region (2026-2031)

5.1.4 Global Subcutaneous Immunoglobulins Sales Value by Region (%), (2020-2031)

5.2 Global Subcutaneous Immunoglobulins Sales Volume by Region

5.2.1 Global Subcutaneous Immunoglobulins Sales Volume by Region: 2020 VS 2024 VS 2031

5.2.2 Global Subcutaneous Immunoglobulins Sales Volume by Region (2020-2025)

5.2.3 Global Subcutaneous Immunoglobulins Sales Volume by Region (2026-2031)

5.2.4 Global Subcutaneous Immunoglobulins Sales Volume by Region (%), (2020-2031)

5.3 Global Subcutaneous Immunoglobulins Average Price by Region (2020-2031)

5.4 North America

5.4.1 North America Subcutaneous Immunoglobulins Sales Value, 2020-2031

5.4.2 North America Subcutaneous Immunoglobulins Sales Value by Country (%), 2024 VS 2031

5.5 Europe

5.5.1 Europe Subcutaneous Immunoglobulins Sales Value, 2020-2031

5.5.2 Europe Subcutaneous Immunoglobulins Sales Value by Country (%), 2024 VS 2031

5.6 Asia Pacific

5.6.1 Asia Pacific Subcutaneous Immunoglobulins Sales Value, 2020-2031

5.6.2 Asia Pacific Subcutaneous Immunoglobulins Sales Value by Region (%), 2024 VS 2031

5.7 South America

5.7.1 South America Subcutaneous Immunoglobulins Sales Value, 2020-2031

5.7.2 South America Subcutaneous Immunoglobulins Sales Value by Country (%), 2024 VS 2031

5.8 Middle East & Africa

5.8.1 Middle East & Africa Subcutaneous Immunoglobulins Sales Value, 2020-2031

5.8.2 Middle East & Africa Subcutaneous Immunoglobulins Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Subcutaneous Immunoglobulins Sales Value Growth Trends, 2020 VS 2024 VS 2031

6.2 Key Countries/Regions Subcutaneous Immunoglobulins Sales Value

6.2.1 Key Countries/Regions Subcutaneous Immunoglobulins Sales Value, 2020-2031

6.2.2 Key Countries/Regions Subcutaneous Immunoglobulins Sales Volume, 2020-2031

6.3 United States

6.3.1 United States Subcutaneous Immunoglobulins Sales Value, 2020-2031

6.3.2 United States Subcutaneous Immunoglobulins Sales Value by Purity (%), 2024 VS 2031

6.3.3 United States Subcutaneous Immunoglobulins Sales Value by Application, 2024 VS 2031

6.4 Europe

6.4.1 Europe Subcutaneous Immunoglobulins Sales Value, 2020-2031

6.4.2 Europe Subcutaneous Immunoglobulins Sales Value by Purity (%), 2024 VS 2031

6.4.3 Europe Subcutaneous Immunoglobulins Sales Value by Application, 2024 VS 2031

6.5 China

6.5.1 China Subcutaneous Immunoglobulins Sales Value, 2020-2031

6.5.2 China Subcutaneous Immunoglobulins Sales Value by Purity (%), 2024 VS 2031

6.5.3 China Subcutaneous Immunoglobulins Sales Value by Application, 2024 VS 2031

6.6 Japan

6.6.1 Japan Subcutaneous Immunoglobulins Sales Value, 2020-2031

6.6.2 Japan Subcutaneous Immunoglobulins Sales Value by Purity (%), 2024 VS 2031

6.6.3 Japan Subcutaneous Immunoglobulins Sales Value by Application, 2024 VS 2031

6.7 South Korea

6.7.1 South Korea Subcutaneous Immunoglobulins Sales Value, 2020-2031

6.7.2 South Korea Subcutaneous Immunoglobulins Sales Value by Purity (%), 2024 VS 2031

6.7.3 South Korea Subcutaneous Immunoglobulins Sales Value by Application, 2024 VS 2031

6.8 Southeast Asia

6.8.1 Southeast Asia Subcutaneous Immunoglobulins Sales Value, 2020-2031

6.8.2 Southeast Asia Subcutaneous Immunoglobulins Sales Value by Purity (%), 2024 VS 2031

6.8.3 Southeast Asia Subcutaneous Immunoglobulins Sales Value by Application, 2024 VS 2031

6.9 India

6.9.1 India Subcutaneous Immunoglobulins Sales Value, 2020-2031

6.9.2 India Subcutaneous Immunoglobulins Sales Value by Purity (%), 2024 VS 2031

6.9.3 India Subcutaneous Immunoglobulins Sales Value by Application, 2024 VS 2031

7 Company Profiles

7.1 Shire (Baxalta)

7.1.1 Shire (Baxalta) Company Information

7.1.2 Shire (Baxalta) Introduction and Business Overview

7.1.3 Shire (Baxalta) Subcutaneous Immunoglobulins Sales, Revenue, Price and Gross Margin (2020-2025)

7.1.4 Shire (Baxalta) Subcutaneous Immunoglobulins Product Offerings

7.1.5 Shire (Baxalta) Recent Development

7.2 Grifols

7.2.1 Grifols Company Information

7.2.2 Grifols Introduction and Business Overview

7.2.3 Grifols Subcutaneous Immunoglobulins Sales, Revenue, Price and Gross Margin (2020-2025)

7.2.4 Grifols Subcutaneous Immunoglobulins Product Offerings

7.2.5 Grifols Recent Development

7.3 CSL

7.3.1 CSL Company Information

7.3.2 CSL Introduction and Business Overview

7.3.3 CSL Subcutaneous Immunoglobulins Sales, Revenue, Price and Gross Margin (2020-2025)

7.3.4 CSL Subcutaneous Immunoglobulins Product Offerings

7.3.5 CSL Recent Development

8 Industry Chain Analysis

8.1 Subcutaneous Immunoglobulins Industrial Chain

8.2 Subcutaneous Immunoglobulins Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Subcutaneous Immunoglobulins Sales Model

8.5.2 Sales Channel

8.5.3 Subcutaneous Immunoglobulins Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Subcutaneous Immunoglobulins Market Trends

Table 2. Subcutaneous Immunoglobulins Market Drivers & Opportunity

Table 3. Subcutaneous Immunoglobulins Market Challenges

Table 4. Subcutaneous Immunoglobulins Market Restraints

Table 5. Global Subcutaneous Immunoglobulins Revenue by Company (2020-2025) & (US$ Million)

Table 6. Global Subcutaneous Immunoglobulins Revenue Market Share by Company (2020-2025)

Table 7. Global Subcutaneous Immunoglobulins Sales Volume by Company (2020-2025) & (K Bottle)

Table 8. Global Subcutaneous Immunoglobulins Sales Volume Market Share by Company (2020-2025)

Table 9. Global Market Subcutaneous Immunoglobulins Price by Company (2020-2025) & (USD/Bottle)

Table 10. Key Manufacturers Subcutaneous Immunoglobulins Manufacturing Base and Headquarters

Table 11. Key Manufacturers Subcutaneous Immunoglobulins Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Subcutaneous Immunoglobulins

Table 13. Global Subcutaneous Immunoglobulins Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Subcutaneous Immunoglobulins as of 2024)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Subcutaneous Immunoglobulins Sales Value by Purity: 2020 VS 2024 VS 2031 (US$ Million)

Table 17. Global Subcutaneous Immunoglobulins Sales Value by Purity (2020-2025) & (US$ Million)

Table 18. Global Subcutaneous Immunoglobulins Sales Value by Purity (2026-2031) & (US$ Million)

Table 19. Global Subcutaneous Immunoglobulins Sales Market Share in Value by Purity (2020-2025)

Table 20. Global Subcutaneous Immunoglobulins Sales Market Share in Value by Purity (2026-2031)

Table 21. Global Subcutaneous Immunoglobulins Sales Volume by Purity: 2020 VS 2024 VS 2031 (K Bottle)

Table 22. Global Subcutaneous Immunoglobulins Sales Volume by Purity (2020-2025) & (K Bottle)

Table 23. Global Subcutaneous Immunoglobulins Sales Volume by Purity (2026-2031) & (K Bottle)

Table 24. Global Subcutaneous Immunoglobulins Sales Market Share in Volume by Purity (2020-2025)

Table 25. Global Subcutaneous Immunoglobulins Sales Market Share in Volume by Purity (2026-2031)

Table 26. Global Subcutaneous Immunoglobulins Price by Purity (2020-2025) & (USD/Bottle)

Table 27. Global Subcutaneous Immunoglobulins Price by Purity (2026-2031) & (USD/Bottle)

Table 28. Global Subcutaneous Immunoglobulins Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)

Table 29. Global Subcutaneous Immunoglobulins Sales Value by Application (2020-2025) & (US$ Million)

Table 30. Global Subcutaneous Immunoglobulins Sales Value by Application (2026-2031) & (US$ Million)

Table 31. Global Subcutaneous Immunoglobulins Sales Market Share in Value by Application (2020-2025)

Table 32. Global Subcutaneous Immunoglobulins Sales Market Share in Value by Application (2026-2031)

Table 33. Global Subcutaneous Immunoglobulins Sales Volume by Application: 2020 VS 2024 VS 2031 (K Bottle)

Table 34. Global Subcutaneous Immunoglobulins Sales Volume by Application (2020-2025) & (K Bottle)

Table 35. Global Subcutaneous Immunoglobulins Sales Volume by Application (2026-2031) & (K Bottle)

Table 36. Global Subcutaneous Immunoglobulins Sales Market Share in Volume by Application (2020-2025)

Table 37. Global Subcutaneous Immunoglobulins Sales Market Share in Volume by Application (2026-2031)

Table 38. Global Subcutaneous Immunoglobulins Price by Application (2020-2025) & (USD/Bottle)

Table 39. Global Subcutaneous Immunoglobulins Price by Application (2026-2031) & (USD/Bottle)

Table 40. Global Subcutaneous Immunoglobulins Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)

Table 41. Global Subcutaneous Immunoglobulins Sales Value by Region (2020-2025) & (US$ Million)

Table 42. Global Subcutaneous Immunoglobulins Sales Value by Region (2026-2031) & (US$ Million)

Table 43. Global Subcutaneous Immunoglobulins Sales Value by Region (2020-2025) & (%)

Table 44. Global Subcutaneous Immunoglobulins Sales Value by Region (2026-2031) & (%)

Table 45. Global Subcutaneous Immunoglobulins Sales Volume by Region (K Bottle): 2020 VS 2024 VS 2031

Table 46. Global Subcutaneous Immunoglobulins Sales Volume by Region (2020-2025) & (K Bottle)

Table 47. Global Subcutaneous Immunoglobulins Sales Volume by Region (2026-2031) & (K Bottle)

Table 48. Global Subcutaneous Immunoglobulins Sales Volume by Region (2020-2025) & (%)

Table 49. Global Subcutaneous Immunoglobulins Sales Volume by Region (2026-2031) & (%)

Table 50. Global Subcutaneous Immunoglobulins Average Price by Region (2020-2025) & (USD/Bottle)

Table 51. Global Subcutaneous Immunoglobulins Average Price by Region (2026-2031) & (USD/Bottle)

Table 52. Key Countries/Regions Subcutaneous Immunoglobulins Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031

Table 53. Key Countries/Regions Subcutaneous Immunoglobulins Sales Value, (2020-2025) & (US$ Million)

Table 54. Key Countries/Regions Subcutaneous Immunoglobulins Sales Value, (2026-2031) & (US$ Million)

Table 55. Key Countries/Regions Subcutaneous Immunoglobulins Sales Volume, (2020-2025) & (K Bottle)

Table 56. Key Countries/Regions Subcutaneous Immunoglobulins Sales Volume, (2026-2031) & (K Bottle)

Table 57. Shire (Baxalta) Company Information

Table 58. Shire (Baxalta) Introduction and Business Overview

Table 59. Shire (Baxalta) Subcutaneous Immunoglobulins Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)

Table 60. Shire (Baxalta) Subcutaneous Immunoglobulins Product Offerings

Table 61. Shire (Baxalta) Recent Development

Table 62. Grifols Company Information

Table 63. Grifols Introduction and Business Overview

Table 64. Grifols Subcutaneous Immunoglobulins Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)

Table 65. Grifols Subcutaneous Immunoglobulins Product Offerings

Table 66. Grifols Recent Development

Table 67. CSL Company Information

Table 68. CSL Introduction and Business Overview

Table 69. CSL Subcutaneous Immunoglobulins Sales (K Bottle), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2020-2025)

Table 70. CSL Subcutaneous Immunoglobulins Product Offerings

Table 71. CSL Recent Development

Table 72. Key Raw Materials Lists

Table 73. Raw Materials Key Suppliers Lists

Table 74. Subcutaneous Immunoglobulins Downstream Customers

Table 75. Subcutaneous Immunoglobulins Distributors List

Table 76. Research Programs/Design for This Report

Table 77. Key Data Information from Secondary Sources

Table 78. Key Data Information from Primary Sources

List of Figures

Figure 1. Subcutaneous Immunoglobulins Product Picture

Figure 2. Global Subcutaneous Immunoglobulins Sales Value, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Global Subcutaneous Immunoglobulins Sales Value (2020-2031) & (US$ Million)

Figure 4. Global Subcutaneous Immunoglobulins Sales Volume (2020-2031) & (K Bottle)

Figure 5. Global Subcutaneous Immunoglobulins Sales Price (2020-2031) & (USD/Bottle)

Figure 6. Subcutaneous Immunoglobulins Report Years Considered

Figure 7. Global Subcutaneous Immunoglobulins Players Revenue Ranking (2024) & (US$ Million)

Figure 8. Global Subcutaneous Immunoglobulins Players Sales Volume Ranking (2024) & (K Bottle)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Subcutaneous Immunoglobulins Revenue in 2024

Figure 10. Subcutaneous Immunoglobulins Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 11. 0.1 Picture

Figure 12. 0.2 Picture

Figure 13. Global Subcutaneous Immunoglobulins Sales Value by Purity (2020 VS 2024 VS 2031) & (US$ Million)

Figure 14. Global Subcutaneous Immunoglobulins Sales Value Market Share by Purity, 2024 & 2031

Figure 15. Global Subcutaneous Immunoglobulins Sales Volume by Purity (2020 VS 2024 VS 2031) & (K Bottle)

Figure 16. Global Subcutaneous Immunoglobulins Sales Volume Market Share by Purity, 2024 & 2031

Figure 17. Global Subcutaneous Immunoglobulins Price by Purity (2020-2031) & (USD/Bottle)

Figure 18. Product Picture of Primary Immunodeficiency

Figure 19. Product Picture of Secondary Immunodeficiency

Figure 20. Product Picture of Others

Figure 21. Global Subcutaneous Immunoglobulins Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)

Figure 22. Global Subcutaneous Immunoglobulins Sales Value Market Share by Application, 2024 & 2031

Figure 23. Global Subcutaneous Immunoglobulins Sales Volume by Application (2020 VS 2024 VS 2031) & (K Bottle)

Figure 24. Global Subcutaneous Immunoglobulins Sales Volume Market Share by Application, 2024 & 2031

Figure 25. Global Subcutaneous Immunoglobulins Price by Application (2020-2031) & (USD/Bottle)

Figure 26. North America Subcutaneous Immunoglobulins Sales Value (2020-2031) & (US$ Million)

Figure 27. North America Subcutaneous Immunoglobulins Sales Value by Country (%), 2024 VS 2031

Figure 28. Europe Subcutaneous Immunoglobulins Sales Value, (2020-2031) & (US$ Million)

Figure 29. Europe Subcutaneous Immunoglobulins Sales Value by Country (%), 2024 VS 2031

Figure 30. Asia Pacific Subcutaneous Immunoglobulins Sales Value, (2020-2031) & (US$ Million)

Figure 31. Asia Pacific Subcutaneous Immunoglobulins Sales Value by Region (%), 2024 VS 2031

Figure 32. South America Subcutaneous Immunoglobulins Sales Value, (2020-2031) & (US$ Million)

Figure 33. South America Subcutaneous Immunoglobulins Sales Value by Country (%), 2024 VS 2031

Figure 34. Middle East & Africa Subcutaneous Immunoglobulins Sales Value, (2020-2031) & (US$ Million)

Figure 35. Middle East & Africa Subcutaneous Immunoglobulins Sales Value by Country (%), 2024 VS 2031

Figure 36. Key Countries/Regions Subcutaneous Immunoglobulins Sales Value (%), (2020-2031)

Figure 37. Key Countries/Regions Subcutaneous Immunoglobulins Sales Volume (%), (2020-2031)

Figure 38. United States Subcutaneous Immunoglobulins Sales Value, (2020-2031) & (US$ Million)

Figure 39. United States Subcutaneous Immunoglobulins Sales Value by Purity (%), 2024 VS 2031

Figure 40. United States Subcutaneous Immunoglobulins Sales Value by Application (%), 2024 VS 2031

Figure 41. Europe Subcutaneous Immunoglobulins Sales Value, (2020-2031) & (US$ Million)

Figure 42. Europe Subcutaneous Immunoglobulins Sales Value by Purity (%), 2024 VS 2031

Figure 43. Europe Subcutaneous Immunoglobulins Sales Value by Application (%), 2024 VS 2031

Figure 44. China Subcutaneous Immunoglobulins Sales Value, (2020-2031) & (US$ Million)

Figure 45. China Subcutaneous Immunoglobulins Sales Value by Purity (%), 2024 VS 2031

Figure 46. China Subcutaneous Immunoglobulins Sales Value by Application (%), 2024 VS 2031

Figure 47. Japan Subcutaneous Immunoglobulins Sales Value, (2020-2031) & (US$ Million)

Figure 48. Japan Subcutaneous Immunoglobulins Sales Value by Purity (%), 2024 VS 2031

Figure 49. Japan Subcutaneous Immunoglobulins Sales Value by Application (%), 2024 VS 2031

Figure 50. South Korea Subcutaneous Immunoglobulins Sales Value, (2020-2031) & (US$ Million)

Figure 51. South Korea Subcutaneous Immunoglobulins Sales Value by Purity (%), 2024 VS 2031

Figure 52. South Korea Subcutaneous Immunoglobulins Sales Value by Application (%), 2024 VS 2031

Figure 53. Southeast Asia Subcutaneous Immunoglobulins Sales Value, (2020-2031) & (US$ Million)

Figure 54. Southeast Asia Subcutaneous Immunoglobulins Sales Value by Purity (%), 2024 VS 2031

Figure 55. Southeast Asia Subcutaneous Immunoglobulins Sales Value by Application (%), 2024 VS 2031

Figure 56. India Subcutaneous Immunoglobulins Sales Value, (2020-2031) & (US$ Million)

Figure 57. India Subcutaneous Immunoglobulins Sales Value by Purity (%), 2024 VS 2031

Figure 58. India Subcutaneous Immunoglobulins Sales Value by Application (%), 2024 VS 2031

Figure 59. Subcutaneous Immunoglobulins Industrial Chain

Figure 60. Subcutaneous Immunoglobulins Manufacturing Cost Structure

Figure 61. Channels of Distribution (Direct Sales, and Distribution)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

What is the annual compound growth rate of the global Subcutaneous Immunoglobulins market size from 2025 to 2031? zhanKai

The annual compound growth rate of the global Subcutaneous Immunoglobulins market is 12.1% 2025 to 2031.

What was the global market size of Subcutaneous Immunoglobulins in 2031? shouQi

What was the global market size of Subcutaneous Immunoglobulins in 2025? shouQi

Which region is expected to have the highest market share? shouQi

Which companies rank high in the global Subcutaneous Immunoglobulins market? shouQi

Related Reports

Global Subcutaneous Immunoglobulins Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Subcutaneous Immunoglobulins market size was US$ 6087 million in 2025 and is forecast to reach a readjusted size of US$ 13360 million by 2032 with a CAGR of 12.1% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 65
USD 4250.00
(Single User License)
Global Subcutaneous Immunoglobulins Market Research Report 2026
The global Subcutaneous Immunoglobulins market was valued at US$ 6087 million in 2025 and is anticipated to reach US$ 13360 million by 2032, at a CAGR of 12.1% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 103
USD 2900.00
(Single User License)
Subcutaneous Immunoglobulins- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Subcutaneous Immunoglobulins was estimated to be worth US$ 6087 million in 2025 and is projected to reach US$ 13360 million, growing at a CAGR of 12.1% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 80
USD 3950.00
(Single User License)
Global Subcutaneous Immunoglobulins Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Subcutaneous Immunoglobulins market is projected to grow from US$ 5491 million in 2024 to US$ 12050 million by 2031, at a CAGR of 12.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-11
Pages: 125
USD 4900.00
(Single User License)
Global Subcutaneous Immunoglobulins Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Subcutaneous Immunoglobulins was estimated to be worth US$ 5491 million and is forecast to reach approximately US$ 12050 million by 2031 with a CAGR of 12.1% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 113
USD 5900.00
(Single User License)
Global Subcutaneous Immunoglobulins Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Subcutaneous Immunoglobulins market size was US$ 5491 million in 2024 and is forecast to a readjusted size of US$ 12050 million by 2031 with a CAGR of 12.1% during the forecast period 2025-2031.
Published Date: 2025-03-19
Pages: 70
USD 4250.00
(Single User License)
Global Subcutaneous Immunoglobulins Market Research Report 2025
The global market for Subcutaneous Immunoglobulins was valued at US$ 5491 million in the year 2024 and is projected to reach a revised size of US$ 12050 million by 2031, growing at a CAGR of 12.1% during the forecast period.
Published Date: 2025-01-16
Pages: 73
USD 2900.00
(Single User License)
Global Subcutaneous Immunoglobulins Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Subcutaneous Immunoglobulin (SCIg) infusions are administered by slowly injecting purified immunoglobulin into fatty tissue underneath the skin. SCIg can be administered at home by patients or carers, using an infusion pump (spring loaded or battery powered) or by rapid push (a manual method that does not require a pump).
Published Date: 2024-04-17
Pages: 121
USD 5600.00
(Single User License)
Global Subcutaneous Immunoglobulins Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Subcutaneous Immunoglobulin (SCIg) infusions are administered by slowly injecting purified immunoglobulin into fatty tissue underneath the skin. SCIg can be administered at home by patients or carers, using an infusion pump (spring loaded or battery powered) or by rapid push (a manual method that does not require a pump).
Published Date: 2024-04-16
Pages: 128
USD 5900.00
(Single User License)
Global Subcutaneous Immunoglobulins Market Insights, Forecast to 2030
Subcutaneous Immunoglobulin (SCIg) infusions are administered by slowly injecting purified immunoglobulin into fatty tissue underneath the skin. SCIg can be administered at home by patients or carers, using an infusion pump (spring loaded or battery powered) or by rapid push (a manual method that does not require a pump).
Published Date: 2024-04-07
Pages: 70
USD 4900.00
(Single User License)

Global Subcutaneous Immunoglobulins Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Subcutaneous Immunoglobulins market size was US$ 6087 million in 2025 and is forecast to reach a readjusted size of US$ 13360 million by 2032 with a CAGR of 12.1% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 65
USD 4250.00 (Single User License)
Global Subcutaneous Immunoglobulins Market Research Report 2026
The global Subcutaneous Immunoglobulins market was valued at US$ 6087 million in 2025 and is anticipated to reach US$ 13360 million by 2032, at a CAGR of 12.1% from 2026 to 2032.
Published: 2026-01-04
Pages: 103
USD 2900.00 (Single User License)
Subcutaneous Immunoglobulins- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Subcutaneous Immunoglobulins was estimated to be worth US$ 6087 million in 2025 and is projected to reach US$ 13360 million, growing at a CAGR of 12.1% from 2026 to 2032.
Published: 2026-01-04
Pages: 80
USD 3950.00 (Single User License)
Global Subcutaneous Immunoglobulins Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Subcutaneous Immunoglobulins market is projected to grow from US$ 5491 million in 2024 to US$ 12050 million by 2031, at a CAGR of 12.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-11
Pages: 125
USD 4900.00 (Single User License)
Global Subcutaneous Immunoglobulins Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Subcutaneous Immunoglobulins was estimated to be worth US$ 5491 million and is forecast to reach approximately US$ 12050 million by 2031 with a CAGR of 12.1% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 113
USD 5900.00 (Single User License)
Global Subcutaneous Immunoglobulins Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Subcutaneous Immunoglobulins market size was US$ 5491 million in 2024 and is forecast to a readjusted size of US$ 12050 million by 2031 with a CAGR of 12.1% during the forecast period 2025-2031.
Published: 2025-03-19
Pages: 70
USD 4250.00 (Single User License)
Global Subcutaneous Immunoglobulins Market Research Report 2025
The global market for Subcutaneous Immunoglobulins was valued at US$ 5491 million in the year 2024 and is projected to reach a revised size of US$ 12050 million by 2031, growing at a CAGR of 12.1% during the forecast period.
Published: 2025-01-16
Pages: 73
USD 2900.00 (Single User License)
Global Subcutaneous Immunoglobulins Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Subcutaneous Immunoglobulin (SCIg) infusions are administered by slowly injecting purified immunoglobulin into fatty tissue underneath the skin. SCIg can be administered at home by patients or carers, using an infusion pump (spring loaded or battery powered) or by rapid push (a manual method that does not require a pump).
Published: 2024-04-17
Pages: 121
USD 5600.00 (Single User License)
Global Subcutaneous Immunoglobulins Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Subcutaneous Immunoglobulin (SCIg) infusions are administered by slowly injecting purified immunoglobulin into fatty tissue underneath the skin. SCIg can be administered at home by patients or carers, using an infusion pump (spring loaded or battery powered) or by rapid push (a manual method that does not require a pump).
Published: 2024-04-16
Pages: 128
USD 5900.00 (Single User License)
Global Subcutaneous Immunoglobulins Market Insights, Forecast to 2030
Subcutaneous Immunoglobulin (SCIg) infusions are administered by slowly injecting purified immunoglobulin into fatty tissue underneath the skin. SCIg can be administered at home by patients or carers, using an infusion pump (spring loaded or battery powered) or by rapid push (a manual method that does not require a pump).
Published: 2024-04-07
Pages: 70
USD 4900.00 (Single User License)